Source: Eur Respir J 2012; 40: 561-569
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stone Helen, McNab Gillian, Wood Alice M., Stockley Robert A., Sapey Elizabeth. Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency},. Eur Respir J 2012; 40: 561-569

Member's Comments

No comment yet.

Related content which might interest you: Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD Source: Eur Respir J 2011; 37: 32-38 Year: 2011 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008 Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 612-617 Year: 2005 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Source: Eur Respir J 2006; 27: 293-299 Year: 2006